LabCompass

Ahmed AbdelKhalek

Medicine · Purdue University West Lafayette

Mid career · publishing since 2016

Publications

28

Citations

903

Est. group size

~1

Recurring co-author estimate

Active years

11

Publishing since 2016

Research summary
AI-generated

Ahmed AbdelKhalek's work focuses on discovering and repurposing drugs to fight difficult bacterial infections, especially Clostridium difficile and antibiotic-resistant bacteria like vancomycin-resistant enterococci and Staphylococcus aureus. Much of this research involves screening existing FDA-approved drugs and testing new chemical compounds to find ones that can kill or block these pathogens. The work sits at the intersection of microbiology and medicinal chemistry, aimed at finding new treatments for hard-to-treat gut and antibiotic-resistant infections.

Clostridium difficile drug discoveryAntimicrobial resistance (e.g., vancomycin-resistant enterococci)Drug repurposing for infectious diseaseAntimicrobial peptides and small moleculesAntibacterial compound screening and medicinal chemistry

Publication output was relatively steady from 2017–2020 (3-5 papers/year) but has slowed considerably since 2021, averaging under 2 papers per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.8/year recently
2017: 5 publications5172018: 5 publications5182019: 3 publications192020: 4 publications20212022: 3 publications222023: 1 publication232024: 1 publication242025: 2 publications252026: 2 publications26
Recent publications
Publishes in
  • Scientific Reports×4
  • PLoS ONE×4
  • Journal of Medicinal Chemistry×3
  • International Journal of Antimicrobial Agents×3
  • The Cambridge Structural Database×3
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 20, 2026.

Claim or correct this profile